CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.10
+0.24 (3.50%)
Sep 13, 2024, 11:49 AM EDT - Market open
CorMedix Market Cap
CorMedix has a market cap or net worth of $396.61 million as of September 13, 2024. Its market cap has increased by 73.57% in one year.
Market Cap
396.61M
Enterprise Value
338.18M
1-Year Change
73.57%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $396.61M, an increase of 1,059.67%. That is a compound annual growth rate of 18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2024 | 386.00M | 87.29% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jin Medical International | 402.33M |
| Emergent BioSolutions | 400.50M |
| Theravance Biopharma | 396.27M |
| Zevra Therapeutics | 388.85M |
| Immutep | 386.13M |
| Korro Bio | 385.62M |
| Monte Rosa Therapeutics | 381.71M |
| Cerus | 379.86M |